Last reviewed · How we verify
NCT05709392: PreDECESS
Preterm DElayed Cord Clamping and Early Skin-to-Skin Contact: PreDECESS
NA trial testing Delayed cord clamping and early skin-to-skin contact in Bonding in 126 participants. Currently enrolling.
11 December 2028
Quick facts
| Lead sponsor | Ostergotland County Council, Sweden |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 126 |
| Start date | 12 December 2022 |
| Primary completion | 11 December 2028 |
| Estimated completion | 11 December 2028 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Delayed cord clamping and early skin-to-skin contact
Conditions studied
- Bonding — all drugs for Bonding →
- Stress — all drugs for Stress →
- Breastfeeding — all drugs for Breastfeeding →
- Child Development — all drugs for Child Development →
Sponsor
Ostergotland County Council, Sweden
Who can join
Adults 30 Weeks to 34 Weeks, any sex, with Bonding or Stress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The PreDECESS trial is a prospective study where that will evaluate a new method taking care of premature infants in gestational weeks 30+0 to 34+6 at birth. The new method includes delayed cord clamping and early skin-to-skin contact with a parent. Two populations of infants with their parents will be compared. Infants taken care of in the traditional way before the new method is introduced, and infants taken care of with the new method when it is being introduced. Primary question: Does delayed cord clamping and early skin-to skin contact (SSC) lead to better bonding between parents and their infants? Secondary questions: Are there any potential adverse effects with delayed cord clamping and early skin-to skin contact (SSC)? Is there a difference in infants level of bilirubin, haemoglobin or proBNP? Is there a difference in infants growth? Is there a difference in infants neurological development? Is there a difference in infants and parents level of stress? Is there a difference in mothers production of breastmilk, frequency of breastfeeding or experience of breastfeeding? Is there a difference in parents mood? How do parents of preterm infants experience giving birth of their preterm baby before and after the introduction of the new method?
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05709392
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bonding
Currently open trials in the same condition.
- NCT07276126 — The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlle · NA · recruiting
- NCT07246356 — Feasibility and Efficacy of GTEP for Birth Trauma · NA · recruiting
Other Ostergotland County Council, Sweden trials
Trials by the same sponsor.
- NCT07254039 — AI-Assisted Saliva Diagnostics Using an Electrochemical Sensor Platform for Periodontitis Detection (SALIENCE) · not yet recruiting
- NCT07007507 — Attendance and Adherence to Aerobic Exercise After Stroke · NA · completed
- NCT06070181 — Effectiveness of Adjunctive Therapy of Emdogain®FL in Non-surgical Periodontal Treatment · NA · recruiting
- NCT06187350 — The Use of AI to Safely Reduce the Workload in Breast Cancer Screening With Mammography in Region Östergötland · completed
- NCT05048095 — Artificial Intelligence in Breast Cancer Screening in Region Östergötland Linkoping · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05709392 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ostergotland County Council, Sweden
- Last refreshed: 2 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05709392.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing